In Vitro Activity of Garenoxacin, a Novel Des-F(6)-quinolone, and Other Orally Administered Antimicrobials Tested Against 50,217 Enterobacteriaceae Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2003)
In Vitro Activity of Garenoxacin, a Novel Des-F(6)-quinolone, and Other Orally Administered Antimicrobials Tested Against 50,217 Enterobacteriaceae Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2003), Lead author: Sader HS, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark
